Combination of high anti‐SKI and low anti‐TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma
Open Access
- 18 April 2024
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 115 (7) , 2209-2219
Abstract
Given that esophageal cancer is highly malignant, the discovery of novel prognostic markers is eagerly awaited. We performed serological identification of antigens by recombinant cDNA expression cloning (SEREX) and identified SKI proto‐oncogene protein and transmembrane p24 trafficking protein 5 (TMED5) as antigens recognized by serum IgG antibodies in patients with esophageal carcinoma. SKI and TMED5 proteins were expressed in Escherichia coli, purified by affinity chromatography, and used as antigens. The serum anti‐SKI antibody (s‐SKI‐Ab) and anti‐TMED5 antibody (s‐TMED5‐Ab) levels were significantly higher in 192 patients with esophageal carcinoma than in 96 healthy donors. The presence of s‐SKI‐Abs and s‐TMED5‐Abs in the patients' sera was confirmed by western blotting. Immunohistochemical staining showed that the TMED5 protein was highly expressed in the cytoplasm and nuclear compartments of the esophageal squamous cell carcinoma tissues, whereas the SKI protein was localized predominantly in the nuclei. Regarding the overall survival in 91 patients who underwent radical surgery, the s‐SKI‐Ab‐positive and s‐TMED5‐Ab‐negative statuses were significantly associated with a favorable prognosis. Additionally, the combination of s‐SKI‐Ab‐positive and s‐TMED5‐Ab‐negative cases showed an even clearer difference in overall survival as compared with that of s‐SKI‐Ab‐negative and s‐TMED5‐Ab‐positive cases. The s‐SKI‐Ab and s‐TMED5‐Ab biomarkers are useful for diagnosing esophageal carcinoma and distinguishing between favorable and poor prognoses.Keywords
Funding Information
- Japan Society for the Promotion of Science (16K10520, 20K16396, 20K17953, 21K08695, 22K07273)
- Japan Agency for Medical Research and Development (21cm0106403h0006)
This publication has 45 references indexed in Scilit:
- Association of elevated autoantibody to high expression of GNAS in hepatocellular carcinomaHeliyon, 2023
- Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinomaEsophagus, 2022
- ZIC2 promotes colorectal cancer growth and metastasis through the TGF-β signaling pathwayExperimental Cell Research, 2022
- The number and ratio of positive lymph nodes are independent prognostic factors for patients with major salivary gland cancer: Results from the surveillance, epidemiology, and End Results datasetEuropean Journal of Surgical Oncology, 2019
- EMT Transition States during Tumor Progression and MetastasisTrends in Cell Biology, 2019
- Prognostic significance of high serum p53 antibody titers in patients with esophageal squamous cell carcinomaEsophagus, 2018
- Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinomaInternational Journal of Cancer, 2004
- Increased expression of c‐Ski as a co‐repressor in transforming growth factor‐β signaling correlates with progression of esophageal squamous cell carcinomaInternational Journal of Cancer, 2004
- Titration of serum p53 antibodies in 1085 patients with various types of malignant tumorsCancer, 2003
- Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinomaCancer, 2000